Prefilled Syringes Market Landscape

The current market landscape features the presence of close to 125 prefilled syringes that are currently available / under development for the delivery of different types of medications. The prefilled syringes market is highly fragmented, featuring the presence of established companies, as well as emerging start-ups. Majority of the companies engaged in this domain are headquartered in Asia-Pacific; of these, over 40% are based India.

Notably, players engaged in this domain are shifting their focus towards the development of plastic prefilled syringes; this can be attributed to the various advantages offered by these syringes, including breakage resistance, light-weight, economical manufacturing and decreased risk of contamination. Further, over 5% of the syringes are available in both glass as well as plastic barrel format.

Most of the prefilled syringes are being developed with luer needle system; these syringes have  threaded rims provides a unique locking system, thereby, preventing the needle from being pulled off by the syringe body inadvertently. Further, prefilled syringes are developed in different volume formats, considering the preferences and needs of the customers.

The prefilled syringes market is anticipated to grow at a steady pace, till 2035

The global prefilled syringes market size is estimated to grow from USD 3.02 billion in 2024 to USD 4.97 billion by 2035, representing a CAGR of 4.6% during the forecast period till 2035.

The different driving factors for the prefilled syringes market include the growing prevalence of chronic diseases (requiring long-term treatments), rising development of biologics (requiring precise dosing) and increasing trend towards self-administration. Our estimates suggest that, in 2023, the maximum revenue generated in this domain is likely to be driven by specialty syringes; this trend is unlikely to change in the foreseen future as well.

Presently, the majority share (50%) of the sales revenues is generated by therapeutic prefilled syringes storing proteins, followed by therapeutic prefilled syringes storing antibodies (31%). It is worth mentioning that, in 2035, blood disorders are likely to dominate the prefilled syringe market.

In terms of type of barrel material, the market is likely to be dominated by glass prefilled syringes. Furthermore, over 70% of the market share is captured by single chamber prefilled syringes; however, the dual chamber prefilled syringes market is anticipated to grow at a relatively faster pace.

In 2023, maximum revenue generated in prefilled syringe domain is likely to be driven by the disposable prefilled syringes, followed by reusable prefilled syringes. In terms of type of syringe, more than 65% share of the market is expected to be captured by safety syringes and is likely to grow at a CAGR of around 7%. It is important to highlight that currently, North America and Europe are likely to capture more than 70% of the overall share in prefilled syringe market.

Innovative Pairing: Prefilled Syringe combination products shaping healthcare

During our research, we identified over 120 drugs that have received approval to be used in combination with prefilled syringes, during the period 2013-2023 (till October) and over 50 drugs that are currently being developed in combination with prefilled syringes.

Majority of the drugs being evaluated in late stages of development (phase I/II or phase III) are targeting autoimmune disorders. It is worth mentioning that subcutaneous route is the most preferred route for drug administration by these combination products due to reduced pain and discomfort, convenient self-administration and stable drug absorption.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/prefilled-syringes-market/284.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.             

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

+1 (415) 800 3415

Sales@rootsanalysis.com